Overexpression of Bcl-xs Sensitizes MCF-7 Cells to Chemotherapy-induced Apoptosis

Cancer Research

Volumn 55, Issue 12, 1995, Pages 2507-2510

  Sumantran, Venil N ^a   Ealovega, Mark W ^a   Nuñez, Gabriel ^a   Clarke, Michael F ^a   Wicha, Max S ^a  

^a UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DNA; ETOPOSIDE; PACLITAXEL; BCL-X PROTEIN; KANAMYCIN KINASE; ONCOGENE PROTEIN E6, HUMAN PAPILLOMAVIRUS TYPE 16; ONCOPROTEIN; PHOSPHOTRANSFERASE; PROTEIN BCL X; PROTO ONCOGENE PROTEINS; RECOMBINANT PROTEIN;

APOPTOSIS; ARTICLE; BREAST CARCINOMA; CELL VIABILITY; CHEMOSENSITIVITY; CONTROLLED STUDY; DIAGNOSIS; DNA DAMAGE; DNA HISTONE INTERACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; ETIOLOGY; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; BIOSYNTHESIS; BREAST TUMOR; CELL CULTURE; CELL DIVISION; CELL LINE; COMPARATIVE STUDY; DRUG EFFECT; GENETIC TRANSFECTION; GENETICS; METABOLISM; WART VIRUS;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BREAST NEOPLASMS; CELL DIVISION; CELL LINE; COMPARATIVE STUDY; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMAN; KANAMYCIN KINASE; ONCOGENE PROTEINS, VIRAL; PACLITAXEL; PAPILLOMAVIRUS, HUMAN; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); PROTO-ONCOGENE PROTEINS; RECOMBINANT PROTEINS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0028979438     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Lowe, S. W., Ruley, H. E., Jacks, T., and Housman, D. E. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell, 74: 957–967, 1993.
2. Chiou, S. K., Rao, L, and White, E. Bcl-2 blocks p53 dependent apoptosis. Mol. Cell. Biol., 14: 2556–2563, 1994.
3. Dole, M., Nunez, G., Merchant, A. K., Maybaum, J., Rode, C. K., Bloch C. A., and Castle, V. P. Bcl-2 Inhibits chemotherapy-induced apoptosis in neuroblastoma. Cancer Res., 54: 3253–3259, 1994.
4. Kamesaki, S., Kamesaki, H., Jorgenson, T. J., Tanizawa, A., Pommier, Y., and Cossman, J. bcl-2 protein inhibits etoposide-induced apoptosis through its effects on events subsequent to topoisomerase II-induced DNA strand breaks and their repair. Cancer Res., 53: 4251–4256, 1993.
5. Qeary, M. L., Smith, S. D., and Sklar, S. J. Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation. Cell, 47: 19–128, 1986.
6. Tsujimoto, Y., and Croce, C. M. Analysis of the structure, transcripts and protein products of bcl-2t the gene involved in follicular lymphoma. Proc. Natl. Acad. Sci. USA, 83: 5214–5218, 1986.
7. Silvestrini, R., Veneroni, S., Daidone, M. G., Benini, E., and Borscchi, P. The Bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer in patients. J. Natl. Cancer Inst., 86: 499–504, 1994.
8. Boise, L. H., Gonzalez-Garcia, M., Postema, C. E., Ding, L., Lindsten, T., Turka, L. A., Mao, X., Nuñez, G., and Thompson, C. B. bclx, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell, 74: 597–608, 1993.
9. Gonzalez-Garcia, M., Garcia, I., Ding, L., Shea, S. O., Boise, L. H., Thompson, C. B., and Nuñez, G. Bcl-x is expressed in embryonic and postnatal neural tissues and functions to prevent neuronal cell death. Proc. Natl. Acad. Sci. USA, 92: in press, 1995.
10. Del Bino, G., Skierski, J. C., and Darzynkiewicz, Z. The concentration dependent diversity of effects of DNA topoisomerase I and II inhibitors on the cell cycle of HL-60 cells. Exp. Cell. Res., 195: 485–491, 1991.
11. Tang, C., Willingham, M. C., Reed, J. C., Miyashita, T., Ray, S., Ponnathpur, V., Huang, Y., Mahoney, M. E., Bullock, G., and Bhalla, K. High levels of p26Bcl-2 oncoprotein retard taxol induced apoptosis in human pre-B leukemia cells. Leukemia (Baltimore), 8: 1960–1969, 1994.
12. Oberhammer, R, Wilson, J., Dive, C., Morris, I. D., Hickman, J. A., Wakeling, A. E., Walker, P. R., and Sikorska, M. Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of interaucleosomal fragmentation. EMBO J., 12: 3679–3684, 1993.
13. Foraari, F. A., Jr. Jarvis, W. D., Grant, S., Orr, M. S., Randolph, J. K., White, F. K., Munaw, V. R., Lovings, E. T., Freeman, R. H., and Gerwitz, D. A. Induction of differentiation and growth arrest is associated with nascent DNA fragmentation and reduced c-myc expression in MCF-7 human breast tumor cells after continous exposure to sublethal concentrations of doxorubicin. Cell Growth & Differ., 5: 723–733, 1994.
14. Takahashi, K., Sumimoto, H., Suzuki, K., and Ono, T. Protein synthesis dependent translocation of p53 protein after serum stimulation of growth arrested MCF-7 cells. Mol. Carcinog., 8: 58–66, 1993.
15. Monaghan, P., Robertson, D., Amos, T. A., Dyer, M. J., Mason, D. V., and Greaves, M. F. Ultrastructural localization of Bcl-2 protein. J. Histochem. Cytochem., 40: 1819–1825, 1992.
16. Martin, M., Lluch, A., Santabarbara, P., Andrew, E., Valverde, J. J., Lopez-Martin, J. A., Rodriguez-Lescure, A., Azagra, P., Garcia-Conde, J., and Diaz-Rubio, E. Clinical activity of chronic oral etoposide in previously treated metastatic breast cancer patients. J. Clin. Oncol., 12: 986–991, 1994.
17. Holmes, F. A., Walters, R. S., Theriault, R. L., Forman, A. D., Newton, L. K., Raber, M. N., Buzdar, A. V., Frye, D., and Hortobagyi, G. N. Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer. J. Natl. Cancer Inst., 83:1797–1805, 1991.
18. Takayama, S., Sato, T., Krajewski, S., Kochel, K., Millan, J. A., and Reed, J. C. Cloning and functional analysis of BAG-1: a novel Bcl-2 binding protein with anti-cell death activity. Cell, 80: 2279–2284, 1995.
19. Oltvai, Z. N., Milliman, C. L., and Korsmeyer, S. J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell, 74: 609–619, 1993.
20. Yang, E., Zha, J., Jockel, J., Boise, L. H., Thompson, C. B., and Korsmeyer, S. J. Bad, a heterodimeric partner for Bclx-L and Bcl-2 displaces Bax and promotes cell death. Cell, 80: 285–291,1995.
21. Sato, T., Hanada, M., Bodrug, S., Irie, S., Iwama, N., Boise, L. H., Thompson, C. B., Golemis, E., Fong, L., Wang, H., and Reed, J. Interactions among members of the Bcl-2 protein family analyzed with a yeast two-hybrid system. Proc. Natl. Acad. Sri. USA, 91: 9238–9242, 1994.